Modeling Gene Regulatory Networks in Development

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

• Build gene regulatory networks by integrating transcription factor motif scans, ChIP-seq binding calls, and ATAC-seq chromatin accessibility data into a weighted edge model.
• Validate each predicted regulatory edge with orthogonal evidence such as expression quantitative trait loci, perturbation experiments, or evolutionary conservation before publishing the network.
• Network inference from multi-omics data remains probabilistic, and every computational prediction requires experimental confirmation in the relevant cell type and developmental stage.

At a Glance

The Core Problem in Gene Regulatory Network Construction

Gene regulatory networks describe how transcription factors, cofactors, chromatin regulators, and cis-regulatory elements control gene expression during development. A researcher who wants to model these networks from multi-omics data faces a distinct problem: each data type provides a partial view of the regulatory process, and no single assay reveals the complete wiring diagram. A transcription factor motif scan identifies potential binding sites in the genome, but many of those sites are never occupied in a given cell type. ChIP-seq reveals where a factor binds in one condition, but the experiment captures only a snapshot and depends on antibody quality. ATAC-seq shows which regions of the genome are accessible, but accessibility does not tell you which protein occupies the open region. RNA-seq tells you which genes are expressed, but expression correlations between a transcription factor and its targets can arise from indirect effects or shared upstream regulators.

The practical consequence is that a network built from any single data type will contain a large number of false positives and false negatives. A researcher who relies only on motif scanning will predict thousands of targets for a single transcription factor, most of which are not bound in the relevant cell type. A researcher who relies only on ChIP-seq will capture binding events but will miss regulatory interactions that occur in other conditions or that depend on chromatin state. A researcher who relies only on ATAC-seq will identify open regions but cannot assign them to specific regulators without additional data.

The solution is to build a network that integrates multiple lines of evidence and assigns confidence scores to each predicted interaction. This approach does not eliminate uncertainty, but it allows the researcher to rank regulatory edges by the strength of the supporting evidence and to prioritize the most likely interactions for experimental validation.

The Biological Basis of Regulatory Information

Gene regulation during development operates through a hierarchy of control mechanisms. Transcription factors bind to specific DNA sequences in promoters, enhancers, silencers, and insulators. The binding of a transcription factor to an enhancer can recruit coactivators or corepressors that modify the local chromatin environment. These modifications include histone acetylation, methylation, and phosphorylation, which change the accessibility of the DNA to the transcriptional machinery. Chromatin remodeling complexes use ATP hydrolysis to slide or evict nucleosomes, exposing or occluding transcription factor binding sites. The combination of transcription factor binding and chromatin state determines whether a gene is transcribed in a particular cell type at a particular developmental time.

The regulatory logic is combinatorial. A single gene may be controlled by multiple enhancers, each active in a different tissue or stage. Each enhancer may contain binding sites for several transcription factors, and the output of the enhancer depends on the cooperative or antagonistic interactions among those factors. This combinatorial logic means that a gene regulatory network cannot be reduced to a simple list of one-to-one interactions. The network must capture the context dependence of each regulatory edge.

The Data Integration Problem

Each experimental assay measures a different layer of the regulatory process. A transcription factor motif scan provides the sequence-level potential for binding. ChIP-seq provides the actual occupancy of a factor across the genome in a specific condition. ATAC-seq provides a genome-wide map of accessible chromatin. RNA-seq provides the expression state of all genes. The researcher must decide how to weight these different layers when constructing the network.

The weighting decision has a large effect on the final network. If the researcher weights motif matches heavily, the network will contain many edges that are not supported by binding data. If the researcher weights ChIP-seq heavily, the network will be biased toward the specific condition and cell type used in the experiment. If the researcher weights ATAC-seq heavily, the network will include many regions that are accessible but not bound by the factor of interest. The correct weighting depends on the biological question and the quality of each data set.

Core Principles of Gene Regulatory Network Modeling

Transcription Factor Motifs as the Sequence-Level Foundation

Transcription factor motifs are position weight matrices that describe the sequence preference of a DNA-binding domain. These motifs are derived from experimental data such as protein binding microarrays, SELEX, or ChIP-seq peak sequences. A motif scan searches a genome for regions that match the position weight matrix above a chosen threshold.

The motif scan provides the first layer of regulatory information. It identifies the potential binding sites for a factor across the genome. The scan is computationally efficient and can be applied to any genome with a known sequence. The limitation is that a motif match does not mean the factor actually binds that site in a living cell. The site may be occluded by nucleosomes, the factor may not be expressed in the cell type of interest, or the factor may require cooperative binding with another protein that is not present.

The researcher must choose a motif score threshold. A low threshold captures more potential sites but increases the false positive rate. A high threshold reduces false positives but may miss genuine binding sites that have weaker sequence matches. The choice of threshold should be guided by the downstream validation strategy. If the network will be tested experimentally, a lower threshold may be acceptable because the validation step will filter out false positives. If the network will be used for hypothesis generation without immediate validation, a higher threshold is safer.

ChIP-seq as the Binding Evidence Layer

ChIP-seq provides direct evidence of transcription factor binding in a specific cell type. The experiment crosslinks proteins to DNA, fragments the chromatin, and uses an antibody specific to the transcription factor to enrich for DNA fragments bound to that factor. The enriched fragments are sequenced and mapped to the genome, producing peaks that represent binding sites.

The quality of ChIP-seq data depends on several factors. The antibody must be specific to the transcription factor of interest and must not cross-react with other proteins. The crosslinking and fragmentation conditions must be optimized for the specific factor. The sequencing depth must be sufficient to detect genuine binding sites above the background. The peak-calling algorithm must be chosen and parameterized appropriately.

ChIP-seq data provide the strongest evidence for a regulatory edge in the network. If a transcription factor binds near a gene promoter or enhancer, that is direct evidence that the factor may regulate the gene. However, binding does not prove regulation. A factor may bind a site without affecting transcription, or the effect may be context dependent. The ChIP-seq data must be combined with expression data to determine whether the binding event is associated with a change in gene expression.

ATAC-seq as the Chromatin Accessibility Layer

ATAC-seq maps open chromatin regions across the genome. The method uses a transposase that preferentially inserts into accessible DNA. The inserted adapters allow the accessible regions to be amplified and sequenced. The resulting peaks represent regions where the chromatin is open and potentially available for transcription factor binding.

ATAC-seq provides a genome-wide view of the regulatory landscape. It identifies enhancers, promoters, and other regulatory elements that are active in a specific cell type. The data are useful for filtering motif matches. A motif match that falls in an open chromatin region is more likely to be a genuine binding site than a motif match in a closed region.

The limitation of ATAC-seq is that it does not identify which factor is bound to the open region. The accessibility signal is factor-agnostic. The researcher must combine ATAC-seq with motif information or ChIP-seq data to assign a specific factor to an open region. ATAC-seq also does not distinguish between different types of open regions. A promoter and an enhancer both appear as open regions, but they have different regulatory functions.

RNA-seq as the Functional Output Layer

RNA-seq measures the expression level of every gene in a cell population. The data provide the functional output of the regulatory network. The expression levels can be compared across conditions, cell types, or developmental stages to identify genes that change in response to a perturbation.

RNA-seq data are used to validate the regulatory edges in the network. If a transcription factor is predicted to regulate a target gene, the expression of the target gene should correlate with the expression or activity of the factor. The correlation can be assessed across a panel of cell types or across a time course. A positive correlation supports the regulatory edge. A negative correlation may indicate a repressive interaction. A lack of correlation does not rule out regulation, because the effect may be context dependent or the factor may act redundantly with other factors.

The RNA-seq data also provide a way to identify the direction of the regulatory interaction. If a transcription factor is knocked down or overexpressed, the expression of its target genes should change in a predictable direction. This perturbation data are the strongest evidence for a regulatory edge, but they are expensive and time consuming to generate.

Practical Workflow for Building a Gene Regulatory Network

Step 1: Define the Regulatory Question and Cell System

The first decision is to define the specific regulatory question. The question determines the data that must be collected and the network that will be built. A researcher studying the regulation of a single gene during a specific developmental transition will need a different network than a researcher studying the global regulatory architecture of a cell type.

The cell system must be defined precisely. The network is built from data collected in a specific cell type at a specific developmental stage. The network does not generalize to other cell types or stages. A transcription factor that regulates a gene in one cell type may not regulate the same gene in another cell type, because the chromatin state and the cofactor environment are different.

The researcher must also define the set of transcription factors to include in the network. The set may be based on prior knowledge of the developmental process, on expression data that identify differentially expressed factors, or on a curated list of all factors in the genome. The choice of the factor set determines the size of the network and the computational cost of the analysis.

Step 2: Collect and Preprocess the Multi-Omics Data

The data collection step must follow standard protocols for each assay. The ChIP-seq experiment requires a validated antibody and appropriate controls. The ATAC-seq experiment requires a sufficient number of cells and appropriate transposition conditions. The RNA-seq experiment requires a sufficient sequencing depth and appropriate biological replicates.

The preprocessing steps are critical for the quality of the final network. The ChIP-seq reads must be aligned to the reference genome, and the peaks must be called with appropriate parameters. The ATAC-seq reads must be aligned, and the peaks must be called with a method that accounts for the transposase bias. The RNA-seq reads must be aligned, and the expression levels must be quantified with a method that accounts for transcript length and library size.

The quality control steps must be applied at each stage. The ChIP-seq data must be checked for the fraction of reads in peaks, the library complexity, and the signal-to-noise ratio. The ATAC-seq data must be checked for the fraction of reads in peaks, the fragment size distribution, and the mitochondrial contamination. The RNA-seq data must be checked for the mapping rate, the gene body coverage, and the correlation between replicates.

Step 3: Integrate the Data Layers

The integration step combines the motif, ChIP-seq, ATAC-seq, and expression data into a single network. The integration can be done in several ways. The simplest approach is to intersect the motif matches with the ChIP-seq peaks and the ATAC-seq peaks. An edge is drawn from the transcription factor to the target gene if the factor has a motif match and a ChIP-seq peak in a regulatory region of the gene and the region is accessible in the ATAC-seq data.

The intersection approach is conservative. It reduces the false positive rate but may miss genuine regulatory edges that are not captured by all three data layers. A more flexible approach is to assign a score to each edge based on the strength of the evidence in each layer. The score can be a weighted sum of the motif score, the ChIP-seq peak strength, and the ATAC-seq peak strength. The weights can be adjusted based on the quality of each data set.

The integration step must also define the regulatory region of each gene. The promoter region is typically defined as the region upstream of the transcription start site. The enhancer regions are more difficult to define because they can be located far from the gene. The enhancer regions can be identified from the ATAC-seq data as accessible regions that are not promoters. The assignment of an enhancer to a target gene requires additional data, such as the correlation between the enhancer accessibility and the gene expression across samples.

Step 4: Validate the Network Edges

The validation step tests the predicted regulatory edges against independent evidence. The strongest validation is a perturbation experiment. The transcription factor is knocked down or overexpressed, and the expression of the target genes is measured. If the target gene expression changes in the predicted direction, the edge is supported.

The perturbation experiment is expensive and time consuming. A less expensive validation is to use expression correlation across a panel of samples. If the expression of the factor and the target gene correlate across many samples, the edge is supported. The correlation does not prove causation, but it provides supporting evidence.

The validation step must also test the network as a whole. The network can be compared to known regulatory interactions from the literature. The network can be tested for its ability to predict the expression of the target genes from the expression of the factors. The network can be tested for its stability across different data sets.

Step 5: Iterate and Refine the Network

The network is not a static product. It must be refined as new data become available. The refinement can involve adding new transcription factors, adding new data layers, or adjusting the edge weights. The refinement can also involve removing edges that are not supported by the validation data.

The iteration step is essential for the network to be useful. A network that is built from a single data set and never validated is a hypothesis, not a model. The network must be tested and refined to become a reliable representation of the regulatory process.

Options and Tradeoffs in Network Construction

Motif Databases and Score Thresholds

The choice of motif database affects the network. Different databases contain different motifs for the same factor, and the motifs may have different position weight matrices. The researcher must choose a database that is appropriate for the factor and the species. The database should be cited in the methods section of any publication.

The score threshold is a key parameter. A low threshold captures more potential sites but introduces more false positives. A high threshold reduces false positives but may miss genuine sites. The threshold should be chosen based on the downstream validation data. If the network is tested with ChIP-seq data, the threshold can be adjusted to maximize the overlap between the motif matches and the ChIP-seq peaks.

ChIP-seq Antibody Quality and Peak Calling

The ChIP-seq antibody is the most important factor in the quality of the data. A poor antibody produces a low signal-to-noise ratio and a high false positive rate. The antibody must be validated for the specific factor and the specific cell type. The validation should include a western blot to confirm the specificity and a test ChIP-seq experiment to confirm the enrichment.

The peak-calling algorithm is another important decision. Different algorithms use different statistical models and produce different peak sets. The algorithm should be chosen based on the data quality and the expected peak characteristics. The peak-calling parameters should be adjusted to the specific data set.

ATAC-seq Data Quality and Peak Calling

The ATAC-seq data quality depends on the number of cells, the transposition efficiency, and the sequencing depth. The data quality can be assessed by the fraction of reads in peaks, the library complexity, and the mitochondrial contamination. The mitochondrial reads should be removed before the peak calling.

The ATAC-seq peak calling is complicated by the transposase bias. The transposase has a sequence preference that can create false peaks. The peak-calling algorithm should account for this bias. The peak-calling parameters should be adjusted to the specific data set.

Expression Data and Correlation Analysis

The expression data are used to validate the network edges. The correlation analysis is a simple method that can be applied to any expression data set. The correlation is calculated between the expression of the factor and the expression of the target gene across samples. The correlation coefficient and the p-value are used to assess the strength of the relationship.

The correlation analysis has limitations. The correlation does not prove causation. The correlation can be confounded by the expression of other factors. The correlation can be affected by the sample size and the distribution of the expression values. The correlation should be used as supporting evidence, not as the sole basis for a regulatory edge.

Common Failure Patterns in Gene Regulatory Network Construction

The Motif-Only Network

A common failure is to build a network from motif matches alone. The motif scan produces a large number of potential binding sites, most of which are not bound in the cell type of interest. The resulting network is dense and contains many false positive edges. The network is not useful for predicting the regulatory relationships because the false positive rate is too high.

The solution is to filter the motif matches with the ATAC-seq data. The motif matches that fall in open chromatin regions are more likely to be genuine binding sites. The motif matches that fall in closed chromatin are likely to be false positives. The ATAC-seq filter reduces the false positive rate and improves the precision of the network.

The ChIP-seq-Only Network

A researcher who builds a network from ChIP-seq data alone will produce a network that is biased toward the specific condition and cell type used in the experiment. The ChIP-seq data capture the binding events in that condition, but they do not capture the binding events that occur in other conditions. The network is not generalizable to other cell types or developmental stages.

The failure is to use the ChIP-seq data as the sole basis for the network. The ChIP-seq data must be combined with the motif data and the ATAC-seq data to identify the binding sites that are functional. The ChIP-seq data must also be combined with the expression data to determine whether the binding is associated with a change in expression.

The Correlation-Only Network

A researcher who builds a network from expression correlation alone will produce a network that is dominated by indirect relationships. The correlation between a factor and a target gene can arise from a shared upstream regulator or from a cofactor. The correlation does not prove that the factor directly regulates the target gene.

The failure is to use the correlation as the sole basis for the network. The correlation must be combined with the motif, ChIP-seq, and ATAC-seq data to identify the direct regulatory edges. The correlation can be used to validate the edges that are predicted by the other data layers.

The Overly Complex Network

A researcher who includes too many transcription factors and too many data layers can produce a network that is too complex to interpret. The network contains so many edges that it is difficult to identify the key regulatory relationships. The network is not useful for hypothesis generation because the signal is lost in the noise.

The failure is to include all possible edges without filtering. The network must be filtered to include only the edges that are supported by multiple lines of evidence. The network must be simplified to include only the factors that are relevant to the specific question.

Records and Measurements for Reproducibility

The Data Provenance Record

The reproducibility of a gene regulatory network depends on the documentation of the data provenance. The researcher must record the source of each data set, the version of the reference genome, the version of the motif database, and the parameters used for each analysis step. The provenance record allows another researcher to reproduce the network from the same data.

The provenance record should include the exact commands used for each analysis step. The record should include the version of each software tool and the parameters used. The record should include the date of the analysis and the person who performed the analysis.

The Quality Control Record

The quality control record documents the quality of each data set. The record should include the metrics for each data set, such as the fraction of reads in peaks, the library complexity, and the signal-to-noise ratio. The record should include the thresholds used to accept or reject each data set.

The quality control record allows the researcher to assess the reliability of the network. A network built from low-quality data is not reliable. The quality control record should be included in the methods section of any publication.

The Validation Record

The validation record documents the results of the validation experiments. The record should include the perturbation experiments, the expression correlation, and the comparison to known regulatory networks. The record should include the results of each validation test and the interpretation of the results.

The validation record is important for the interpretation of the network. A network that has been validated by multiple independent methods is more reliable than a network that has not been validated. The validation record should be included in the publication.

Biosafety and Regulatory Context for the Laboratory Work

Biosafety Principles for the Experimental Work

The laboratory work involved in generating the multi-omics data must follow the biosafety principles described in the Biosafety in Microbiological and Biomedical Laboratories. The researcher must assess the risk of the biological materials used in the experiments. The risk assessment must consider the cell types, the vectors, and the reagents used.

The researcher must use the appropriate containment level for the experimental materials. The containment level is determined by the risk assessment. The researcher must follow the institutional biosafety committee requirements. The researcher must use the appropriate personal protective equipment and follow the standard laboratory practices.

Recombinant and Synthetic Nucleic Acid Oversight

The experiments that involve recombinant or synthetic nucleic acid molecules must follow the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. The researcher must determine whether the experimental protocol falls under the guidelines. The researcher must follow the appropriate containment and the appropriate oversight procedures.

The researcher must register the experimental protocol with the institutional biosafety committee. The committee reviews the protocol and determines the appropriate containment level. The researcher must follow the approved protocol and the approved containment procedures.

The Measurement Science Context

The quality of the data depends on the measurement science. The NIST Laboratory Programs provide the standards and the calibration procedures for the measurement. The researcher must use the appropriate standards and the calibration procedures for the data collection.

The measurement science is important for the reproducibility of the data. The data must be collected with the appropriate calibration and the appropriate quality control. The data must be reported with the appropriate uncertainty. The measurement science ensures that the data are reliable and reproducible.

The Role of the MIQE Guidelines in the Expression Data

The MIQE Guidelines for the qPCR Data

The MIQE guidelines provide the minimum information for the publication of the quantitative real-time PCR experiments. The guidelines are relevant to the gene regulatory network because the qPCR is used to validate the expression changes. The researcher must follow the MIQE guidelines when reporting the qPCR data.

The MIQE guidelines require the researcher to report the experimental design, the sample preparation, the primer sequences, the amplification conditions, and the data analysis. The guidelines require the researcher to report the controls and the normalization. The guidelines require the researcher to report the reproducibility and the statistical analysis.

The MIQE Guidelines for the RNA-seq Data

The MIQE guidelines are specific to the qPCR, but the principles apply to the RNA-seq data. The researcher must report the experimental design, the sample preparation, the library preparation, the sequencing, and the data analysis. The researcher must report the quality control and the normalization.

The MIQE guidelines emphasize the transparency and the reproducibility. The researcher must report the data in a way that allows the other researchers to reproduce the experiment. The researcher must report the data in a way that allows the other researchers to interpret the data.

The Role of the Laboratory Protocols in the Data Collection

The Addgene Protocols for the Molecular Biology

The Addgene protocols provide the educational context for the molecular biology workflows. The protocols are not universally validated, but they provide the practical planning for the data collection. The researcher must use the protocols as a starting point and adapt them to the specific experimental system.

The Addgene protocols cover the cloning, the transformation, the transfection, and the other molecular biology techniques. The protocols are useful for the construction of the reporter constructs and the perturbation vectors. The researcher must validate the protocols for the specific cell type and the specific experimental system.

The Adaptation of the Protocols to the Specific System

The researcher must adapt the protocols to the specific cell type and the specific experimental system. The protocol that works for one cell type may not work for another. The researcher must optimize the protocol for the specific system.

The optimization involves the testing of the different conditions and the selection of the best condition. The researcher must test the different transfection reagents, the different cell densities, and the different time points. The researcher must select the condition that produces the best results.

The Interpretation of the Network and the Limitations

The Network Is a Model, Not a Complete Representation

The gene regulatory network is a model of the regulatory relationships. The model is a simplification of the biological reality. The model does not capture all the regulatory interactions. The model does not capture the dynamics of the regulatory process.

The researcher must interpret the network as a model. The network is a hypothesis about the regulatory relationships. The network is a tool for the hypothesis generation. The network is not a complete representation of the regulatory process.

The Context Dependence of the Regulatory Edges

The regulatory edges in the network are context dependent. The edge may be active in one cell type and not in another. The edge may be active at one developmental stage and not at another. The edge may be active in one condition and not in another.

The researcher must interpret the network in the context of the data. The network is built from the data collected in a specific cell type and a specific condition. The network does not generalize to the other cell types and the other conditions.

The Need for the Experimental Validation

The network is a computational prediction. The prediction must be validated by the experimental data. The validation is the only way to confirm the regulatory relationships. The validation is the only way to determine the direction of the regulatory relationships.

The researcher must validate the network before using the network for the hypothesis generation. The validation must be performed with the appropriate experimental methods. The validation must be performed with the appropriate controls.

The Professional Escalation Criteria

When to Seek the Expert Help

The researcher should seek the expert help when the data quality is poor. The researcher should seek the expert help when the network is not converging. The researcher should seek the expert help when the validation experiments are not producing the expected results.

The expert help can be obtained from the bioinformatics core facility, the statistics department, or the collaborators. The expert help can be obtained from the literature and the online resources. The expert help can be obtained from the professional societies and the conferences.

When to Reconsider the Data

The researcher should reconsider the data when the quality control metrics are not met. The researcher should reconsider the data when the data are not reproducible. The researcher should reconsider the data when the data are not consistent with the known biology.

The researcher should reconsider the data when the network is not producing the expected results. The researcher should reconsider the data when the validation experiments are not supporting the network. The researcher should reconsider the data when the network is not useful for the hypothesis generation.

When to Publish the Network

The researcher should publish the network when the network has been validated. The researcher should publish the network when the network is reproducible. The researcher should publish the network when the network is useful for the hypothesis generation.

The researcher should publish the network with the data and the methods. The researcher should publish the network with the quality control and the validation. The researcher should publish the network with the limitations and the interpretation.

Frequently Asked Questions

What is the difference between a motif scan and a ChIP-seq experiment?

A motif scan identifies the sequence matches for a transcription factor across the genome. The scan is a computational prediction of the potential binding sites. A ChIP-seq experiment identifies the actual binding sites for the factor in a specific cell type. The ChIP-seq data are the experimental evidence for the binding. The motif scan is the sequence-level prediction, and the ChIP-seq is the binding-level evidence.

How do I choose the threshold for the motif score?

The threshold for the motif score is a tradeoff between the sensitivity and the specificity. A low threshold captures more potential sites but introduces more false positives. A high threshold reduces the false positives but may miss the genuine sites. The threshold should be chosen based on the downstream validation data. The threshold can be adjusted to the overlap between the motif matches and the ChIP-seq peaks.

What is the difference between the ATAC-seq and the ChIP-seq?

ATAC-seq identifies the open chromatin regions across the genome. The data are factor-agnostic and do not identify which factor is bound. ChIP-seq identifies the binding sites for a specific factor. The data are factor-specific and identify the binding sites for the factor of interest. The ATAC-seq data are used to filter the motif matches, and the ChIP-seq data are used to identify the binding sites.

How do I validate a predicted regulatory edge?

The validation can be performed by the perturbation experiment. The transcription factor is knocked down or overexpressed, and the expression of the target gene is measured. The validation can also be performed by the expression correlation across the samples. The validation can also be performed by the comparison to the known regulatory networks. The validation is the only way to confirm the regulatory edge.

What is the best way to integrate the multi-omics data?

The best way to integrate the data is to assign a score to each edge based on the evidence in each layer. The score can be a weighted sum of the motif score, the ChIP-seq peak strength, and the ATAC-seq peak strength. The score can be adjusted based on the quality of each data set. The integration should be performed with the appropriate computational tools.

How do I know if my network is reliable?

The network is reliable if it has been validated by the experimental data. The network is reliable if it is reproducible from the same data. The network is reliable if it is consistent with the known biology. The network is reliable if it is useful for the hypothesis generation. The network is not reliable if it is built from a single data set and has not been validated.

What are the common mistakes in the network construction?

The common mistakes include the use of the motif matches alone, the use of the ChIP-seq data alone, the use of the correlation alone, and the use of the overly complex network. The mistakes produce the networks with the false positives and the false negatives. The mistakes produce the networks that are not useful for the hypothesis generation.

How do I report the network in a publication?

The network should be reported with the data and the methods. The network should be reported with the quality control and the validation. The network should be reported with the limitations and the interpretation. The network should be reported in a way that allows the other researchers to reproduce the network.

Using the Evidence

Related Molecular Biology Guides

• Multi-Omics Approaches: Integrating Biological Data for Systems-Level Insights
• Chromatin Modification: How Cells Control Gene Activity
• Integrating Multi-Omics: Methods, Challenges, and Best Practices
• Transcription Factors: Mechanisms, Regulation, and Roles in Gene Expression
• Epigenetics Books for Beginners: A Guide to Gene Regulation

References and Further Reading

• Molecular Biology and Laboratory Methods. National Library of Medicine.
• Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
• NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules. National Institutes of Health.
• Addgene Protocols. Addgene.
• MIQE Guidelines. Clinical Chemistry.
• NIST Laboratory Programs. National Institute of Standards and Technology.
• Benchmarking algorithms for gene regulatory network inference from single-cell transcriptomic data.. Nature methods, 2020.
• A gene regulatory network for root hair development.. Journal of plant research, 2019.
• Gene regulatory network from cranial neural crest cells to osteoblast differentiation and calvarial bone development.. Cellular and molecular life sciences : CMLS, 2022.
• RegVelo: Gene-regulatory-informed dynamics of single cells.. Cell, 2026.
• Fate and state transitions during human blood vessel organoid development.. Cell, 2025.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.